Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Federal Trade Commission
Julphar
McKesson
Moodys
US Department of Justice
Citi
McKinsey
Cantor Fitzgerald
Fuji
Chinese Patent Office

Generated: February 20, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020507

« Back to Dashboard

NDA 020507 describes TECZEM, which is a drug marketed by Biovail and is included in one NDA. Additional details are available on the TECZEM profile page.

The generic ingredient in TECZEM is diltiazem malate; enalapril maleate. There are twenty-six drug master file entries for this compound. Additional details are available on the diltiazem malate; enalapril maleate profile page.
Summary for 020507
Tradename:TECZEM
Applicant:Biovail
Ingredient:diltiazem malate; enalapril maleate
Patents:0
Formulation / Manufacturing:see details

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:TABLET, EXTENDED RELEASE;ORALStrengthEQ 180MG HCL;5MG
Approval Date:Oct 4, 1996TE:RLD:No

Expired US Patents for NDA 020507

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Biovail TECZEM diltiazem malate; enalapril maleate TABLET, EXTENDED RELEASE;ORAL 020507-001 Oct 4, 1996 ➤ Try a Free Trial ➤ Try a Free Trial
Biovail TECZEM diltiazem malate; enalapril maleate TABLET, EXTENDED RELEASE;ORAL 020507-001 Oct 4, 1996 ➤ Try a Free Trial ➤ Try a Free Trial
Biovail TECZEM diltiazem malate; enalapril maleate TABLET, EXTENDED RELEASE;ORAL 020507-001 Oct 4, 1996 ➤ Try a Free Trial ➤ Try a Free Trial
Biovail TECZEM diltiazem malate; enalapril maleate TABLET, EXTENDED RELEASE;ORAL 020507-001 Oct 4, 1996 ➤ Try a Free Trial ➤ Try a Free Trial
Biovail TECZEM diltiazem malate; enalapril maleate TABLET, EXTENDED RELEASE;ORAL 020507-001 Oct 4, 1996 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
Citi
Colorcon
Fish and Richardson
Moodys
Healthtrust
Medtronic
Cantor Fitzgerald
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot